06.18.07: Drug Delivery Report
An analyst and top management from 3 firms examine the Drug Delivery sector in this 17 page report from The Wall Street Transcript.

  1. Drug Delivery Technologies: Matthew Kaplan, Punk, Ziegel & Company

  2. CEO Interviews (average 2,500 words): Top management from 3 sector firms examine the outlook for their firm and sector. Firms interviewed include: CellCyte Genetics Corporation, Durect Corporation and NexMed, Inc.

    Topics covered: Proprietary technologies - FDA approval strategies - Inhaled insulin market - Regulatory validating events - Big Pharma product pipeline - De-risked programs

    Companies covered: Flamel Technologies (FLML), GlaxoSmithKline (GSK), Sonus Pharmaceuticals (SNUS), Aradigm (ARDM), Novo Nordisk (NVO), Pfizer (PFE) and United Therapeutics (UTHR).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE